CN107714849A - 一种治疗心肌缺血的中药组合物及其制备方法 - Google Patents
一种治疗心肌缺血的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN107714849A CN107714849A CN201711133545.XA CN201711133545A CN107714849A CN 107714849 A CN107714849 A CN 107714849A CN 201711133545 A CN201711133545 A CN 201711133545A CN 107714849 A CN107714849 A CN 107714849A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- myocardial ischemia
- medicine composition
- active component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 208000031225 myocardial ischemia Diseases 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 38
- 241000208688 Eucommia Species 0.000 claims abstract description 16
- 241001079002 Melicope pteleifolia Species 0.000 claims abstract description 16
- 241000521581 Millettia Species 0.000 claims abstract description 16
- 235000004263 Ocotea pretiosa Nutrition 0.000 claims abstract description 16
- 244000009660 Sassafras variifolium Species 0.000 claims abstract description 16
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 15
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 52
- 239000000284 extract Substances 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000000706 filtrate Substances 0.000 claims description 19
- 238000001914 filtration Methods 0.000 claims description 18
- 238000000605 extraction Methods 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 3
- 230000003071 parasitic effect Effects 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 2
- 230000024241 parasitism Effects 0.000 abstract description 10
- 239000008280 blood Substances 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 9
- 229920002472 Starch Polymers 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- 239000008107 starch Substances 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- 239000006188 syrup Substances 0.000 description 8
- 235000020357 syrup Nutrition 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000004334 sorbic acid Substances 0.000 description 4
- 235000010199 sorbic acid Nutrition 0.000 description 4
- 229940075582 sorbic acid Drugs 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- 241001148495 Cibotium barometz Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 244000173782 Ficus hirta Species 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Chemical class 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 241000800405 Spatholobus suberectus Species 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000001913 cellulose Chemical class 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Chemical class 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 229920001223 polyethylene glycol Chemical class 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000727551 Ampelopsis aconitifolia Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 241001115458 Carphophis Species 0.000 description 1
- 244000050510 Cunninghamia lanceolata Species 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000195958 Dicksoniaceae Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- 241000219428 Fagaceae Species 0.000 description 1
- 108010010803 Gelatin Chemical class 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000208682 Liquidambar Species 0.000 description 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
- 241000221040 Loranthaceae Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000134888 Santalales Species 0.000 description 1
- 241000501113 Sargentodoxa cuneata Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241001528016 Ventilago Species 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000008273 gelatin Chemical class 0.000 description 1
- 229920000159 gelatin Chemical class 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- -1 liquid paraffin Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000008441 qiangxin fumai Substances 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗心肌缺血的中药组合物及其制备方法。该中药是由狗脊、杜仲、三叉苦、枫荷桂、鸡血藤、龙眼寄生、熟地、过山龙、五指毛桃等中药原料制备而成的。本发明还提供了这种中药组合物的制备方法。本发明提供的中药组合物主要用于治疗心肌缺血。
Description
技术领域
本发明涉及中药领域,具体涉及一种治疗心肌缺血的中药组合物及其制备方法。
背景技术
心肌缺血是心血管系统常见病,可引起心绞痛、心律失常、心肌梗死等病症。
本病属祖国医学的胸痹、心悸范畴,其病位在心,累及肺脾肝肾诸脏。由于脏腑功能失调,使气血津液生化及运行障碍,引起气滞、血瘀、痰积(聚)等病理变化,从而影响心主血脉运行全身的功能,使心脉痹阻、心失所养,故而发病。
心血瘀阻型 症见心胸憋闷疼痛,痛引肩背,肢麻,唇甲青紫,舌质紫暗或有瘀斑,苔薄,脉涩或结代。治法:行气活血、化瘀通脉。
痰浊壅盛型 症见胸闷气短,肢体沉重,痰多恶心,纳差,舌质淡胖,苔白腻,脉弦滑。治法:通阳宣痹、化痰降浊。
心阴两虚型 症见胸闷,心悸气短,头晕乏力,失眠多梦,舌质淡红,苔薄或少津,脉细无力。治法:益气养阴通脉。
心肾阳虚型 症见心悸气短,胸闷,乏力,汗出,畏寒肢冷,舌质淡或胖,苔薄,脉沉细或结代。治法:益气温阳、强心复脉。
发明内容
本发明的目的是提供一种治疗心肌缺血的中药组合物;
本发明的另一目的是提供一种治疗心肌缺血的中药组合物的制备方法。
本发明的目的是通过下列的技术方案实现的:
本发明所述的治疗心肌缺血的中药组合物,是由如下重量份的中药原料制备而成的:
狗脊30-50份、杜仲5-20份、三叉苦5-20份、枫荷桂5-20份、鸡血藤10-30份、龙眼寄生20-40份、熟地10-30份、过山龙10-30份、五指毛桃10-30份。
优选地,是由如下重量份的中药原料制备而成的:
狗脊35-45份、杜仲10-15份、三叉苦10-15份、枫荷桂10-15份、鸡血藤15-25份、龙眼寄生25-35份、熟地15-25份、过山龙15-25份、五指毛桃15-25份。
以下是本发明中药制剂的药材来源:
狗脊,为蚌壳蕨科植物金毛狗脊Cibotium barometz(L.)J.Sm.的干燥根茎。苦、甘,温。归肝、肾经。补肝肾,强腰脊,祛风湿。用于腰膝酸软,下肢无力,风湿痹痛。
杜仲,为杜仲科植物杜仲Eucommia ulmoides Oliv. 的干燥树皮。甘,温。归肝、肾经。补肝肾,强筋骨,安胎。用于肾虚腰痛,筋骨无力,妊娠漏血,胎动不安;高血压。
三叉苦,芸香科吴茱萸属植物三叉苦Evodia lepta (Spreng.) Merr.,以根及叶入药。苦,寒。清热解毒、祛风除湿。治咽喉肿痛、风湿骨痛、疟疾、黄疸、湿疹、皮炎、跌打损伤及虫蛇咬伤等症。
枫荷桂,为樟科植物檫木的根或茎、叶,祛风除湿,活血散瘀,止血,主风湿痹痛,跌打损伤,腰肌劳损,半身不遂,外伤出血。
鸡血藤,为豆科植物密花豆(大血藤、血风藤、三叶鸡血藤、九层风)Spatholobussuberectus Dunn 的干燥藤茎。苦、甘,温。归肝、肾经。补血,活血,通络。用于月经不调,血虚萎黄,麻木瘫痪,风湿痹痛。
龙眼寄生,檀香目,桑寄生科,灌木。寄生于壳斗科、山茶科、桑科植物或枫香、油桐、杉树等多种植物上。甘;苦;性平;祛风湿;补肝肾;活血止痛;止咳;止痢。主风湿痹痛;腰膝酸痛;头晕目眩;脱发;跌打损伤;痔疮肿痛;咳嗽;咳血;痢疾
熟地,为玄参科植物地黄或怀庆地黄的根茎,经加工蒸晒而成。甘,微温。归肝、肾经。滋阴补血,益精填髓。用于肝肾阴虚,腰膝酸软,骨蒸潮热,盗汗遗精,内热消渴,血虚萎黄,心悸怔忡,月经不调,崩漏下血,眩晕,耳鸣,须发早白。
过山龙,为葡萄科植物乌头叶蛇葡萄的根皮。辛;热。归心;肾经。祛风除湿;散瘀消肿。主风寒湿痹;跌打瘀肿;痈疽肿痛
五指毛桃,为桑科榕属植物粗叶榕Ficus simplicissima Lour.[F. hirta Vahl var.palmatiloba (Merr.)Chum],以根入药。甘,微温。健脾化湿,行气化痰,舒筋活络。用于肺结核咳嗽,慢性支气管炎,风湿性关节炎,腰腿疼,脾虚浮肿,病后盗汗,白带。
本发明的另一方面是提供了本发明中药组合物的活性成分的制备方法,该方法是采用水提或40-80%体积百分浓度的乙醇提取制备而成。具体制备方法如下:
方案一:取全部药材,混合后加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为1-3小时,合并提取液,滤过,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,即得活性成分。
方案二:取全部药材,混合后用40-80%乙醇回流提取2-3次,每次乙醇用量为药材总量的4-10倍,提取时间为1-4小时,合并提取液,过滤,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,即得活性成分。
方案三:取全部药材,混合后加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为1-3小时,合并提取液,滤过,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,加入乙醇,使含醇量为40-70%,静置12-24小时,滤过,滤液浓缩至70-80℃时相对密度为1.10-1.25的浸膏,即得活性成分。
本发明所述的治疗心肌缺血的中药组合物,还可以与医药学上可接受的载体配合,制成各种口服制剂,如丸剂、片剂、胶囊剂、口服液、糖浆剂、合剂等。
本发明的药学上可接受的载体包括但不限于以下:
口服制剂:
稀释剂:淀粉、糖粉、乳糖、糊精、微晶纤维素、无机盐、糖醇类等。
润湿剂与粘合剂:纯化水、乙醇、明胶、聚乙二醇、纤维素衍生物等。
崩解剂:淀粉、羧甲基淀粉钠、纤维素衍生物、交联聚维酮等。
润滑剂:硬脂酸镁、微粉硅胶、滑石粉、聚乙二醇等。
助溶剂:水、乙醇、甘油、丙二醇、液状石蜡、植物油等。
矫味剂:蔗糖、单糖、芳香剂等。
防腐剂:苯甲酸、山梨酸、甲酯、乙酯、丙酯等。
方法1:片剂
取方案一至方案三所得活性成分之一,加入片剂常用辅料,按常规生产方法制备得本发明片剂。
上述片剂常用辅料包括稀释剂、润湿剂、粘合剂、崩解剂、润滑剂之一或全部。
方法2:胶囊剂
取方案一至方案三所得活性成分之一,加入胶囊剂常用辅料,按常规生产方法制备得本发明胶囊剂。
上述胶囊剂常用辅料包括稀释剂、润湿剂、粘合剂、崩解剂、润滑剂之一或全部。
方法3:糖浆剂
取方案一至方案三所得活性成分之一,加入糖浆剂常用辅料,按常规生产方法制备得本发明糖浆剂。
上述糖浆剂常用辅料包括矫味剂、防腐剂、助溶剂之一或全部。
方法4:合剂
取方案一至方案三所得活性成分之一,加入合剂常用辅料,按常规生产方法制备得本发明合剂。
上述合剂常用辅料包括矫味剂、防腐剂之一或全部。
方法5:口服液
取方案一至方案三所得活性成分之一,溶解后净化、浓缩,加入口服液常用辅料,按常规生产方法制备得本发明口服液。
本发明提供的一种治疗心肌缺血的中药组合物具有以下优点:
1、本发明提供的组合物制剂安全有效,全方相互配合,共奏补肝肾、滋补气血、活血舒筋之功,用于心肌缺血及心肌缺血所致的双腿麻的治疗。
2、经临床试验证明,用本发明对心肌缺血患者治疗后,有效率达93.4%,表明本发明能有效治疗心肌缺血。
3、本发明提供的中药组合物制剂,配方科学合理,工艺简单,口感好,成本低。
具体实施方式
下面通过实施例进一步说明本发明。应该理解的是,本发明的实施例是用于说明本发明而不是对本发明的限制。根据本发明的实质对本发明进行的简单改进都属于本发明要求保护的范围。除非另有说明,本发明中的乙醇量的百分数是体积百分数,v/v表示溶液的体积比。
实施例1 片剂
称取狗脊30g、杜仲5g、三叉苦5g、枫荷桂5g、鸡血藤10g、龙眼寄生20g、熟地10g、过山龙10g、五指毛桃10g。加水提取3次,三次加水量分别为药材总重量的12倍、8倍、6倍,三次提取时间分别为3小时、2小时、1小时,合并提取液,滤过,滤液浓缩至70℃时相对密度为1.25的清膏,加入辅料淀粉、乙醇、滑石粉,制得片剂。
实施例2 颗粒剂
称取狗脊50g、杜仲20g、三叉苦20g、枫荷桂20g、鸡血藤30g、龙眼寄生40g、熟地30g、过山龙30g、五指毛桃30g。用乙醇回流提取2次,每次乙醇浓度分别为80%、60%,每次乙醇用量分别为药材总量的10倍、8倍,提取时间分别为4小时、3小时,合并提取液,过滤,滤液浓缩至80℃时相对密度为1.10的浸膏,加入淀粉、糊精,制粒、干燥、整粒即得。
实施例3 糖浆剂
称取狗脊35g、杜仲10g、三叉苦10g、枫荷桂10g、鸡血藤15g、龙眼寄生25g、熟地15g、过山龙15g、五指毛桃15g。加水提取2次,每次加水量分别相当于药材总重量的12倍、10倍,每次提取时间分别为3小时、2小时,合并提取液,滤过,滤液浓缩至80℃下相对密度为1.05的清膏,加入乙醇,使含醇量为70%,静置12小时,滤过,滤液浓缩至70℃时相对密度为1.25的浸膏,在浸膏中加入糖浆剂辅料蔗糖、山梨酸、水搅拌均匀,制得糖浆剂。
实施例4 胶囊剂
称取狗脊45g、杜仲15g、三叉苦15g、枫荷桂15g、鸡血藤25g、龙眼寄生35g、熟地25g、过山龙25g、五指毛桃25g。用40%乙醇回流提取3次,每次乙醇用量分别为药材总量的10倍、8倍、4倍,提取时间分别3小时、2小时、1小时,合并提取液,过滤,滤液浓缩60℃时相对密度为1.25的浸膏,在浸膏中加入辅料淀粉、乙醇、糊精、硬脂酸镁,按常规方法制成胶囊剂。
实施例5 颗粒剂
称取狗脊40g、杜仲12g、三叉苦12g、枫荷桂12g、鸡血藤20g、龙眼寄生30g、熟地20g、过山龙20g、五指毛桃20g。加水提取2次,两次加水量分别为药材总重量的10倍、8倍,两次提取时间分别为2小时、1小时,合并提取液,滤过,滤液浓缩至80℃时相对密度为1.10的浸膏。加入淀粉、糊精,制粒、干燥、整粒即得。
实施例6 片剂
称取狗脊32g、杜仲8g、三叉苦8g、枫荷桂8g、鸡血藤11g、龙眼寄生23g、熟地11g、过山龙11g、五指毛桃11g。加水提取3次,三次加水量分别相当于药材总重量的12倍、8倍、6倍,每次提取时间分别3小时、2小时、1小时,合并提取液,滤过,滤液浓缩至70℃时相对密度为1.20的清膏,加入乙醇,使含醇量为40%,静置24小时,滤过,滤液浓缩至滤液浓缩至70℃时相对密度为1.10的浸膏,加入辅料淀粉、乙醇、滑石粉,制得片剂。
实施例7 合剂
称取狗脊38g、杜仲11g、三叉苦11g、枫荷桂11g、鸡血藤18g、龙眼寄生28g、熟地18g、过山龙18g、五指毛桃18g。加水提取3次,三次加水量分别相当于药材总重量的12倍、8倍、6倍,每次提取时间分别3小时、2小时、1小时,合并提取液,滤过,滤液浓缩至总重量为药材总重量的3倍,灌装,加入合剂辅料蔗糖、乙酯、水、山梨酸搅拌均匀,制得合剂。
实施例8 口服液
称取狗脊42g、杜仲14g、三叉苦13g、枫荷桂14g、鸡血藤23g、龙眼寄生32g、熟地23g、过山龙23g、五指毛桃23g。加水提取2次,两次加水量分别为药材总重量的10倍、8倍,两次提取时间分别为2小时、1小时,合并提取液,滤过,滤液浓缩至80℃时相对密度为1.10的浸膏,在浸膏中加入辅料甘露醇、山梨酸、水搅拌均匀,分装,制得口服液。
实施例9 粉剂
称取狗脊48g、杜仲18g、三叉苦18g、枫荷桂18g、鸡血藤28g、龙眼寄生38g、熟地28g、过山龙28g、五指毛桃28g。粉碎,过筛,即得。
实施例10
本发明实施例4所制备的胶囊剂,给予心肌缺血患者口服,每次2例,每日3次,临床数据如下:
病症类别 | 病症例数 | 病程 | 治疗时间 | 有效人数 | 总有效率 |
心肌缺血 | 137 | 1-5年 | 15-20月 | 128人 | 93.4% |
实施例11
张某,因下肢麻木3个月加重5天就诊。既往心肌缺血5年,平素无症状。给予本发明实施例8治疗,一周后下肢麻木症状消失。
虽然,上文中已经用一般性说明、具体实施方式及试验,对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
Claims (7)
1.一种治疗心肌缺血的中药组合物,其特征在于它是由如下重量份的中药原料制备而成的:
狗脊30-50份、杜仲5-20份、三叉苦5-20份、枫荷桂5-20份、鸡血藤10-30份、龙眼寄生20-40份、熟地10-30份、过山龙10-30份、五指毛桃10-30份。
2.如权利要求1所述的治疗心肌缺血的中药组合物,其特征在于它是由包括如下重量份的中药原料制备而成的:
狗脊35-45份、杜仲10-15份、三叉苦10-15份、枫荷桂10-15份、鸡血藤15-25份、龙眼寄生25-35份、熟地15-25份、过山龙15-25份、五指毛桃15-25份。
3.如权利要求1或2所述的治疗心肌缺血的中药组合物,其特征在于它的活性成分是采用水提或40-80%体积百分浓度的乙醇提取制备而成。
4.如权利要求3所述的治疗心肌缺血的中药组合物,其特征在于它的活性成分是通过以下方法制备而成的:取全部药材,混合后加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为1-3小时,合并提取液,滤过,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,即得活性成分。
5.如权利要求3所述的治疗心肌缺血的中药组合物,其特征在于它的活性成分是通过以下方法制备而成的:取全部药材,混合后用40-80%乙醇回流提取2-3次,每次乙醇用量为药材总量的4-10倍,提取时间为1-4小时,合并提取液,过滤,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,即得活性成分。
6.如权利要求3所述的治疗心肌缺血的中药组合物,其特征在于它的活性成分是通过以下方法制备而成的:取全部药材,混合后加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为1-3小时,合并提取液,滤过,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,加入乙醇,使含醇量为40-70%,静置12-24小时,滤过,滤液浓缩至70-80℃时相对密度为1.10-1.25的浸膏,即得活性成分。
7.一种治疗心肌缺血的制剂,由权利要求1-6所述的治疗心肌缺血的中药组合物与医药学上可接受的载体配合制备而成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711133545.XA CN107714849A (zh) | 2017-11-16 | 2017-11-16 | 一种治疗心肌缺血的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711133545.XA CN107714849A (zh) | 2017-11-16 | 2017-11-16 | 一种治疗心肌缺血的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107714849A true CN107714849A (zh) | 2018-02-23 |
Family
ID=61216769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711133545.XA Pending CN107714849A (zh) | 2017-11-16 | 2017-11-16 | 一种治疗心肌缺血的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107714849A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1175461A (zh) * | 1997-10-01 | 1998-03-11 | 黄治源 | 一种治疗心脑血管疾病药物组合物及其制备方法 |
CN1626195A (zh) * | 2004-08-11 | 2005-06-15 | 凌沛学 | 一种治疗冠心病心绞痛的中药制剂及其制备方法 |
CN1733081A (zh) * | 2005-08-25 | 2006-02-15 | 贵州益佰制药股份有限公司 | 一种具有养血安神的中药制剂及其制备方法 |
CN101983714A (zh) * | 2010-11-08 | 2011-03-09 | 西安谦坤商务咨询管理有限公司 | 一种治疗心绞痛的中药组合物及其制备方法 |
CN103083473A (zh) * | 2011-11-08 | 2013-05-08 | 谢朝云 | 一种治疗心脏病的药物及其制备方法 |
-
2017
- 2017-11-16 CN CN201711133545.XA patent/CN107714849A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1175461A (zh) * | 1997-10-01 | 1998-03-11 | 黄治源 | 一种治疗心脑血管疾病药物组合物及其制备方法 |
CN1626195A (zh) * | 2004-08-11 | 2005-06-15 | 凌沛学 | 一种治疗冠心病心绞痛的中药制剂及其制备方法 |
CN1733081A (zh) * | 2005-08-25 | 2006-02-15 | 贵州益佰制药股份有限公司 | 一种具有养血安神的中药制剂及其制备方法 |
CN101983714A (zh) * | 2010-11-08 | 2011-03-09 | 西安谦坤商务咨询管理有限公司 | 一种治疗心绞痛的中药组合物及其制备方法 |
CN103083473A (zh) * | 2011-11-08 | 2013-05-08 | 谢朝云 | 一种治疗心脏病的药物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103169928B (zh) | 治疗痛经的外用中药组合物及其制备方法和应用 | |
CN103751635A (zh) | 一种治疗黄褐斑的中药面膜及其制备方法 | |
CN104138550A (zh) | 一种治疗消化性溃疡药物的制备方法 | |
CN103463297B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法和用途 | |
CN101214306B (zh) | 一种治疗高血压的中草药 | |
CN101417086B (zh) | 一种治疗心肌缺血的中药制剂 | |
CN103990079A (zh) | 用于治疗气滞血瘀型腰肌劳损的药物组合物及其制备方法 | |
CN103202956A (zh) | 一种降血压养生保健药酒 | |
CN103920058A (zh) | 一种治疗头痛的中药制剂及其制备方法 | |
CN107714849A (zh) | 一种治疗心肌缺血的中药组合物及其制备方法 | |
CN104825956A (zh) | 防治中风、康复筋骨关节的药 | |
CN102228596B (zh) | 一种药物组合物及制剂及在治疗冠心病、心绞痛中的应用 | |
CN102908425A (zh) | 一种治疗心脏病及血脂稠的药物及其制备方法 | |
CN102935156B (zh) | 一种治疗骨质增生症的丸剂 | |
CN101518579B (zh) | 一种稳压疏通药及制备工艺 | |
CN105833055A (zh) | 一种治疗“三高”的中药组合物、其制备方法和应用 | |
KR20090085237A (ko) | 천연 진주가루를 함유한 뇌질환 예방 및 치료용 한약조성물 | |
CN102423367B (zh) | 一种养颜活血药 | |
CN101390960A (zh) | 一种治疗气虚肾亏血瘀型骨质疏松症的药物组合物及其制备方法 | |
CN106421165A (zh) | 一种治疗外阴瘙痒的中药组合物及其制备方法 | |
CN105832934A (zh) | 一种治疗高血压病的中药 | |
CN103083552B (zh) | 一种用于治疗神经性皮肤炎症的药丸 | |
CN105456933A (zh) | 一种活血化瘀、通经活络的中药及其制备方法 | |
CN105168804A (zh) | 用于治疗心肌梗塞的中药组合物 | |
CN104997881A (zh) | 一种可治疗增生性脊椎炎的汤剂药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180223 |
|
WD01 | Invention patent application deemed withdrawn after publication |